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Abstract: Basidiomycetes of the genus Hericium are among the most praised medicinal and
edible mushrooms, which are known to produce secondary metabolites with the potential to treat
neurodegenerative diseases. This activity has been attributed to the discovery of various terpenoids
that can stimulate the production of nerve growth factor (NGF) or (as established more recently)
brain-derived neurotrophic factor (BDNF) in cell-based bioassays. The present study reports on
the metabolite profiles of a Lion’s Mane mushroom (Hericium erinaceus) strain and a strain of the
rare species, Hericium flagellum (synonym H. alpestre). While we observed highly similar metabolite
profiles between the two strains that were examined, we isolated two previously undescribed
metabolites, given the trivial names erinacines Z1 and Z2. Their chemical structures were elucidated
by means of nuclear magnetic resonance (NMR) spectroscopy and high resolution mass spectrometry.
Along with six further, previously identified cyathane diterpenes, the novel erinacines were tested for
neurotrophin inducing effects. We found that erinacines act on BDNF, which is a neurotrophic factor
that has been reported recently by us to be induced by the corallocins, but as well on NGF expression,
which is consistent with the literature.
Keywords: natural products; fungal metabolites; neurotrophic activity; fermentation; Basidiomycota
1. Introduction
Neurotrophins such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF)
are important for the survival, maintenance, and regeneration of specific neuronal populations in the
adult brain. Therefore they can be used as a remedy in the fight against neurodegenerative diseases
such as Parkinson’s, Alzheimer’s and Huntington’s diseases, which are accompanied by decreased
neurotrophic factor expression [1]. Chemical constituents from Hericium erinaceus promote neuronal
survival and potentiate neurite outgrowth via the TrkA/Erk1/2 pathway. Since neurotrophins are not
able to pass the blood brain barrier (BBB) due to their high molecular weights, NGF-inducing small
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molecules and NGF mimics became the focus of research activities [2,3]. In the domain of natural
product research, several NGF-inducing constituents that are derived from different sources have been
reported [4,5], and among the first were secondary metabolites of H. erinaceus. This edible mushroom
has a long history of usage in traditional Chinese medicine and is used in various food supplements
and nutraceuticals [6,7]. From the basidiomes and corresponding mycelial cultures, various terpenoids
were isolated that possessed immunomodulatory, anti-inflammatory, anti-proliferative, antimicrobial,
and neuritogenic activities [7–10]. Interestingly, both the erinacine type cyathane diterpenoids that
were produced in mycelial cultures and the hericenone type meroterpenoids that are located in
the basidiomes of H. erinaceus, have been found to stimulate NGF synthesis [7]. We have recently
discovered new compounds of the latter type from basidiomes of the related species Hericium coralloides,
which were the first members of this compound family that modulated both, NGF and BDNF
production. This prompted us to extend our studies to the metabolites from cultures of other Hericium
species. The present study is dedicated to a comparison of the secondary metabolite profiles of
two strains from this genus. Aside from a strain of H. erinaceus that was derived from a specimen
that was collected in Southwest Germany, we used another strain of the rare species, H. flagellum
(synonym: H. alpestre) that was deposited many years ago in a public culture collection. The latter
species is associated with conifers, in particular Abies, and has to our knowledge never been studied
for secondary metabolites. The terpenoids of both strains were isolated to purity and subsequently
examined in our bioassays, in order to evaluate their neurotrophic activities.
2. Results and Discussion
2.1. Secondary Metabolites of Hericium erinaceus and Hericium flagellum
Mycelial cultures of H. erinaceus and H. flagellum were examined for their secondary metabolites
profiles and the results of this study are presented in Table 1. Two new erinacine derivatives (1) and
(2) and six known compounds, erinacine A (3) [6], erinacine B (4) [6], erinacine C (5) [6], erinacine E
(6) [11], CJ14.258 (7), and erinacine F (8) [11] were structurally characterized (Figure 1). Dominant
compounds in the extracts of both the strains were cyathane diterpenoids (Table 1) with almost no
difference in the variety of diterpenoids isolated. Although observed from H. flagellum only, 7 and 8
were reported to be produced by other species from the genus Hericium [11]. Further work involving
additional strains and culture media will show whether there are specific metabolies that are produced
by certain species of the genus; however, the current study confirmed the apparent specificity of
cyathane diterpenes as prevailing metabolites of Hericium species.
2.2. Structure Elucidation of Compounds 1–8
The chemical structures of the new compounds were elucidated by Electrospray ionization-mass
spectrometry (ESI-MS) and interpretation of two-dimensional (2D) NMR data. The known compounds
were identified by comparing their spectroscopic data with those reported in the literature.
Table 1. Comparison of secondary metabolites isolated from the cultures of H. erinaceus and H. flagellum.
Compounds H. erinaceus H. flagellum
Erinacine Z1 (1) + −
Erinacine Z2 (2) − +
Erinacine A (3) + +
Erinacine B (4) + +
Erinacine C (5) + +
Erinacine E (6) + +
CJ14.258 (7) − +
Erinacine F (8) − +
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for C26H41O7 [M + H]+; m/z = 465.2847), consistent with the molecular formula C26H40O7 indicating 7 
degrees of unsaturation. The 1H NMR spectrum of (1) (Table 2) displayed four methyl signals at δH 
0.93 (3H, s), 0.99 (3H, s), 0.97 (6H, d, J = 6.8 Hz) and 3.26 (3H, s), which is characteristic of a methoxy 
group and twenty proton signals in the δH 1.32–4.65 ppm range. In addition the 1H spectrum revealed 
one olefinic proton at δH 6.94 (1H, dd, J = 5.6, 1.2 Hz) and a singlet at δH 9.54 (1H, s) characteristic of 
an aldehyde. The 13C NMR and heteronuclear single quantum coherence- distortionless enhancement 
by polarization transfer (HSQC-DEPT) spectra implied the presence of five non-proton-bearing 
carbons, including three olefinic (δC 139.9, 136.6, 138.6) and two aliphatic carbons (δC 40.6, 49.2). 
Furthermore, five methylene groups with corresponding carbons between δC 28.4–38.5 ppm, a 
further oxygenated methylene group at δC 65.1, viscinal to two aliphatic methines between δC 27.0 
and δC 40.4, and six methines at δC 69.6–105.3 ppm were observed. A carbonyl carbon at δC 192.9 
with the corresponding proton signal at δH 9.54 suggested the presence of an aldehyde moiety. 1H-
1H-COSY (COrrelated SpectroscopY) and heteronuclear multiple bond correlation (HMBC) 
correlations clearly indicated a presence of a [5-6-7] tricyclic carbon skeleton with an isopropyl group 
connected to the olefinic carbon at δC 139.9 (C-3) and an allylic aldehyde located at the seven-
membered ring (C-13, C-12, C-15) in 1.  
Additionally, COSY correlations between the methylene protons at C-10 and the proton at δH 
4.63 as well as 2J-HMBC correlations of this proton to methylene carbon C-10 and olefinic carbon C-
12 and 3J-HMBC correlations to the methoxy carbon C-21, the olefinic carbon C-13 and the carbonyl 
carbon C-15 pointed to a methoxy group next to the allylic aldehyde at C-11 (Figure 2a). Further 
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Compound (1) was obtained as colorless oil and exhibited a major peak in the High
resolution-Electrospray ionization-mass spectrometry (HR-ESIMS) spectrum at m/z = 465.2853
([M + H]+, calcd. for C26H41O7 [M + H]+; m/z = 465.2847), consistent with the molecular formula
C26H40O7 indicating 7 degrees of unsaturation. The 1H NMR spectrum of (1) (Table 2) displayed
four methyl signals at δH 0.93 (3H, s), 0.99 (3H, s), 0.97 (6H, d, J = 6.8 Hz) and 3.26 (3H, s), which is
characteristic of a methoxy group and twenty proton signals in the δH 1.32–4.65 ppm range. In addition
the 1H spectrum revealed one olefinic proton at δH 6.94 (1H, dd, J = 5.6, 1.2 Hz) and a singlet at
δH 9.54 (1H, s) characteristic of an aldehyde. The 13C NMR and heteronuclear single quantum
coherence- distortionless enhancement by polarization transfer (HSQC-DEPT) spectra implied the
presence of five non-proton-bearing carbons, including three olefinic (δC 139.9, 136.6, 138.6) and
two aliphatic carbons (δC 40.6, 49.2). Furthermore, five methylene groups with corresponding
carbons between δC 28.4–38.5 ppm, a further oxy enated methylene group at δC 65.1, viscinal to two
aliphatic methines betwe n δC 27.0 and δC 40.4, nd six me ines at δC 69.6–105.3 ppm were observed.
A carbonyl carbon at δC 192.9 with the corresponding proto signal at δH 9.54 suggested the presence
of an aldehyd moiety. 1H-1H-COSY (COrrelated Spectros opY) and het ronuclear multiple bond
correlation (HMBC) corr latio s clearly indicated a presence of a [5-6-7] tricyclic carbon skeleton with
an isopropyl group connected to the olefinic carbon at δC 139.9 (C-3) and an allylic aldehyde located at
the seven-membered ring (C-13, C-12, C-15) in 1.
Additionally, COSY correlations between the methylene protons at C-10 and the proton at
δH 4.63 as well as 2J-HMBC correlations of this proton to methylene carbon C-10 and olefinic
carbon C-12 and 3J-HMBC correlations to the methoxy carbon C-21, the olefinic carbon C-13 and
the carbonyl carbon C-15 pointed to a methoxy group next to the allylic aldehyde at C-11 (Figure 2a).
Further studies of the 2D NMR data (HSQC, COSY, HMBC, and rotating-frame nuclear Overhauser
effect correlation spectroscopy; ROESY) revealed a β-D-xylopyranose, which is commonly attached to
cyathane diterpenoids via carbons C-13 and/or C-14. The downfield shift of the proton and carbon
signals of the C-14 suggested a position adjacent to an oxygen atom and the HMBC correlation to
methine (C-1′) of the xyloside led to the structure of compound 1.
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The comparison of the NMR signals of 1 with literature values of structurally similar cyathane
xylosides such as erinacine P [12] confirmed its structure. The relative stereochemical structure of
1 was determined by ROESY and NOESY experiments, which exhibited correlations of proton H-5,
methyl group CH3-17, methylene protons H-7a and H-10a as well as methine proton H-11. On the
other hand correlations between methyl group CH3-16, methine proton H-14 and methylene protons
H-7b and H-10b could be observed (Figure 2b).
Compound (2) was also isolated as colorless oil. The [M + H]+ peak at m/z =451.2689 ([M + H]+,
calcd. for C25H39O7 [M + H]+, m/z = 451.2690) in the HR-ESI-MS spectrum provided the molecular
formula C25H38O7 with 7 degrees of unsaturation. The 1H NMR data of 2 revealed four methyl groups
at δH 0.82 (3H, s), δH 0.97 (6H, m), and δH 1.14 (3H, s), twenty protons in the δH 1.16–4.78 ppm range,
an olefinic proton at δH 7.01 (1H, dd, J = 7.3, 0.9 Hz), and a singlet at δH 9.43 (1H, s), similar to compound
1. Also, the 13C shifts and correlations of the HSQC-DEPT spectrum showed high similarity to 1 and
suggested that compound 2 was a derivative of the cyathane diterpenoid 1. The major difference
between the two compounds spectra was the missing methoxy group at C-11 in 2. The analysis of the
COSY and HMBC data revealed the same proton-proton and proton-carbon long range correlations of
methine H-11 at δH 4.78 (1H, br d, J = 5.2 Hz) and δC 62.1 as in compound 1, but the high field shift of
the carbon signal and the compound mass of 2 were consistent with the presence of a hydroxyl group at
C-11 instead of a methoxy moiety. Similar to compound 1, the ROESY spectrum displayed correlations
between proton H-5, methyl group CH3-17, methylene proton H-10a and methine proton H-11,
indicating that all of them have the same stereochemical orientation. Additionally, ROE correlations
between the methyl group CH3-16 and the methine proton H-14 could be observed, which finally led
to the 11-hydroxy derivative 2.
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2.3. NGF-Induced Neurite Outgrowth in PC12 Cells
All of the isolated metabolites were evaluated for their neurotrophin inducing effects.
Immortalized PC12 cells derived from rat adrenal medullary tumor (pheochromocytoma) cells and that
are widely employed as an in vitro model for neuronal differentiation and neurite outgrowth studies
were used. PC12 cells require NGF to differentiate, upon which they stop proliferating, extend neurites,
and become electrically excitable [13]. A direct neurotrophic effect of the test compounds was analyzed
by incubating PC12 cells in the highest non-toxic concentration of each compound in serum-free
medium. Murine salivary gland extract, which is known to contain NGF, was used as a positive
control causing PC12 cell differentiation. In this experimental setup, no signs of neurite outgrowth
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from PC12 cells were observed (Figure 3a), indicating that none of the tested diterpenoids exerted a
direct neurotrophic effect.
Table 2. 1H and 13C NMR data of erinacine Z1 (1; 500 MHz and 125 MHz in CDCl3) and
erinacine Z2 (2; 700 MHz and 175 MHz in acetone-d6). Corresponding spectra are deposited in
the Supplementary Materials.
Position
(1) (2)
δC, Type δH, m (J in Hz) δC, Type δH, m (J in Hz)
1 38.5, CH2 1.46, m; 1.62, m 38.3, CH2 1.54, m
2 28.4, CH2 2.27, m 29.1, CH2 2.31, m
3 139.9, C 140.7, C
4 136.6, C 139.8, C
5 40.4, CH 1.93, m 36.1, CH 3.47, m
6 40.6, C 44.5, C
7a 30.4, CH2 1.32, td (12.2, 6.6) 34.3, CH2 1.16, m
7b 1.62, m 2.41, td (13.8, 4.2)
8 37.0, CH2 1.46, m 37.1, CH2 1.44, ddd (12.5, 7.7, 3.0) 1.54, m
9 49.2, C 50.4, C
10b 30.1, CH2 1.81, ddd (14.2, 11.9, 5.5) 35.0, CH2 2.07, m
10a 2.54, dd (13.7, 10.1) 2.14, m
11 72.4, CH 4.63, m 62.1, CH 4.78, br d (5.2)
12 138.6, C 148.2, C
13 158.2, CH 6.94, dd (5.6, 1.2) 154.6, CH 7.01, dd (7.3, 0.9)
14 85.4, CH 4.61, d (5.6) 85.3, CH 3.96, d (7.3)
15 192.9, CH 9.54, s 194.2, CH 9.43, s
16 16.4, CH3 0.99, s 16.4, CH3 0.82, s
17 24.5, CH3 0.93, s 24.7, CH3 1.14, s
18 27.0, CH 2.85, m 27.7, CH 3.08, m
19 21.5, CH3 0.97, d (6.8) 22.0, CH3 0.97, m
20 21.8, CH3 0.97, d (6.8) 22.3, CH3 0.97, m
21 56.6, CH3 3.26, s -
1′ 105.3, CH 4.34, d (7.0) 106.3, CH 4.56, d (5.6)
2′ 73.5, CH 3.47, m 74.6, CH 3.51, m
3′ 69,6, CH 3.74, td (8.8, 5.1) 70.3, CH 3.51, m
4′ 75.7, CH 3.54, dd (8.8) 73.3, CH 3.41, dd (7.3, 5.8)
5′ 65.1, CH2
3.29, m
3.99, dd (11.7, 5) 65.0, CH2
3.28, dd (11.8, 7.5)
3.88, dd (11.8, 3.3)
Since PC12 cells do not produce NGF themselves [13], we used human 1321N1 astrocytoma
cells to test for the induction of cyathane-induced NGF secretion. As a negative control, ethanol was
used according to the final concentration of the dissolved compounds. Subsequently, the conditioned
astrocyte media were used to incubate PC12 cells. All tested compounds displayed PC12 differentiation
activity triggering neurite outgrowth (Figure 3b) with respect to both the number of differentiating
PC12 cells as well as the length of induced neurite outgrowth (Figure 3c). These findings suggest that
the metabolites isolated from cultures of Hericium erinaceus and flagellum possess neurotrophin-inducing
properties in astrocytic cells with compounds 3, 4, 5, 6, and 7 being most potent. The new metabolites
1 and 2 exhibited relatively weak effects on PC12 cell differentiation.
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2.4. Semi-Quantitative Reverse Transcriptase PCR to Quantify the Neurotrophin mRNA Level
To directly confirm induction of neurotrophin expression in 1321N1 cells by tested compounds
1321N1 cells were incubated with these compounds for 6 h, followed by RNA isolation, cDNA
synthesis, and semi-quantitative RT-PCR analysis. Ubiquitously expressed glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as a reference to determine relative amounts of NGF (Figure 4a)
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and BDNF induction (Figure 4b), respectively. Supporting the results of the PC12 differentiation assays,
compounds 3, 4, 5, 7, and but also the new derivative 1 showed an increase of NGF mRNA between
1.4 and 2 folds. Out of those, compounds 3, 4, 5 and 7 induced higher levels of NGF expression than
compound 1, in agreement with the results of the PC12 differentiation assays. Likewise, compound 2
treatment did not result in the induction of NGF expression consistent with its poor performance in the
PC12 differentiation assay. Intriguingly 6 did not result in the induction of elevated NGF expression in
contrast to its strong neurite extension activity in the PC12 assay. Either 6 induces NGF expression in
1321N1 cells with a lag phase or currently unknown factors with PC12 differentiation-inducing activity
are released into the medium by 6 treated astrocytic cells.
Another prominent neurotrophic factor is BDNF; but because PC12 cells do not express its
high-affinity receptor tropomyosin receptor kinase B (TrkB) [14,15], BDNF is not able to trigger
neurite outgrowth in PC12 cells. Semi-quantitative RT-PCR revealed that of all applied compounds
only 5 harbors BDNF-inducing properties at moderate levels, similar to the recently characterized
corallocins [6]. In addition to that, erinacines contain different neurotrophin-inducing signatures,
with some being able to induce a cocktail of neurotropohin-secretion from astrocytes.
Compounds 3, 4, 5, 7, and the novel derivative 1 were found to act on the 1321N1 cells by
increasing the transcription of either BDNF or NGF. Among all of the compounds that were tested,
6 and 2 failed to induce neurotrophin production.
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Figure 4. Semiquantitative RT-PCR analysis for mRNA of (a) nerve growth factor (NGF) and
(b) brain-derived neurotrophic factor (BDNF); (a) A significant increase of NGF was observed for
several cyathane derivatives tested. Compounds 3, 4, and 7 increased NGF mRNA by two times,
compounds 5 increase NGF by 1.6 times, whereas 2 and 6 failed to induce NGF mRNA upregulation;
(b) Only 1321N1 incubated with 5 show a significantly higher BDNF mRNA amount when compared
to the ethanol control (±SEM; a, p < 0.05).
3. Materials and Methods
3.1. General Experimental Procedures
On -dimensional (1D) and 2D NMR spectra were recorded on an Avance III 700 spectrom ter
(Bruker, Bremen, Germany); with a 5 m TXI cryoprobe (1H 700 MHz, 13C 175 MHz) or
an Avance III 500 (1H 500 MHz, 13C 125 MHz) spectrometer (Bruker); optical rotations were
measured on a Perkin-Elmer 241 polarimeter, IR spectra were measured with a Nicolet Spectrum
100 FTIR spectrometer (Perkin-Elmer, Waltham, MA, USA). All of the HPLC analyses were
performed on a 1200 Series (Agilent, Santa Clara, CA, USA), equipped with degasser, Bin Pump
SL (Agilent technologies 1260 Infinity), autosampler and DAD/electron light scattering detector
Corona Ultra RS. C18 Acquity UPLC BEH column (2.1 × 50 mm, 1.7 µm; Waters, Eschborn, Germany)
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was used. Solvent A: H2O + 0.1% formic acid, solvent B: acetonitrile + 0.1% formic acid with the
following gradient: 0–0.5 min 5% B, 0.5–20.0 min 100% B, 20–30 min 100% B; injection volume was
2 µL, flow rate 600 µL/min; UV/Vis detection 200–600 nm.
LC-ESI-MS spectra were recorded on an ion trap mass spectrometer (scan range 100–2000 m/z,
capillary voltage 4000 V, dry temperature 250 ◦C) (amaZon speed, Bruker), and HR-ESI-MS spectra
on a time-of-flight (TOF) mass spectrometer (scan range 250–25000 m/z, capillary voltage 4500 V,
dry temperature 200 ◦C) (MaXis, Bruker).
The chemicals and solvents were obtained from AppliChem GmbH (Darmstadt, Germany),
Avantor Performance Materials (Deventor, The Netherlands), Carl Roth GmbH & Co. KG
(Karlsruhe, Germany), and Merck KGaA (Darmstadt, Germany) in analytical and HPLC grade.
3.2. Fungal Material and Fermentation
Hericium erinaceus strain STMA 06157B was isolated from the basidiome of a specimens that
were collected by Benno Stadler in Germany, Rhenania-Palatinate Province, near Eppenbrunn on
Fagus sylvatica in September of 2006. The culture and the corresponding specimen are deposited
at the herbarium and culture collection of the DSMZ, Braunschweig, Germany. Hericium flagellum
(deposited as “H. alpestre” strain CBS 103681 had been originally isolated by N. Hallenberg from a
specimens collected from Abies in Romania and was purchased from Westerdijk Fungal Biodiversity
Centre (Utrecht, The Netherlands).
A seed culture of H. erinaceus was prepared as follows: five mycelial plugs (0.5 × 0.5 cm2)
were cut from well grown yeast-malt-glucose agar (YMG) plates and were inoculated in 2 × 100 mL
ZM/2 medium [16]. Flasks were incubated on a rotary shaker for 168 h at 24 ◦C and 160 rpm. 4 × 40 mL
of the first inoculum was added in 4 × 1000 mL sterile Erlenmeyer flasks with 400 mL working
volume of ZM/2 medium and incubated at the same conditions. A 10 L batch bioreactor, containing
ZM/2 medium, equipped with temperature control, pH controller, and agitation, was inoculated with
10% of the seed culture, fermented for 72 h at 24 ◦C and 150 rpm. Finally it served as a seed culture for
a 70 L bioreactor (10% seed culture added, fermented for 192 h at 24 ◦C and 150 rpm).
Hericium flagellum was fermented in two different media, ZM/2 and SP [D(+) glucose monohydrate
30 g/L, soy peptone 6 g/L, KH2PO4 2.5 g/L, MgSO4 0.5 g/L, yeast extract 1.5 g/L, CaCl2·2H2O
73.5 mg/L, pH 6.0; after autoclaving 1 mL/L trace element solution sterile filtrated-FeCl3·6H2O
80 mg/L, MnSO4·H2O 30 mg/L, ZnSO4·H2O 90 mg/L, EDTA 400 mg/L]. Fifteen 500 mL Erlenmeyer
flasks containing 200 mL media were used for each media and later incubated on a rotary shaker for
97 days (ZM/2 medium) and 60 days (SP medium), respectively, at 24 ◦C and 160 rpm.
3.3. Extraction and Isolation
The biomass (1240 g) of H. erinaceus was extracted with 6L of acetone according to the protocol
of Chepkirui et al. [17] to yield 12.5 g of the crude extract, whereas the culture broth was incubated
with 1% (v/v) of Amberlite XAD™-16N adsorber resin (Sigma-Aldrich, Deisenhofen, Germany) under
stirring for 1 h. The resin was thereafter removed by filtration and subsequently extracted, according
to the aforementioned extraction protocol [17], to give 6 g of crude extract.
The biomass and supernatant of H. flagellum were separated by filtration and extracted as
described by Chepkirui et al. [17]. From the fermentation carried out in ZM/2 medium 454 mg
and 65 mg of crude extracts were obtained from supernatant and biomass, respectively.
The crude mycelial extract obtained from H. erinaceus was subjected to Flash chromatography
on a Reveleris X2 system (Grace, Columbia, MD, USA) using a normal phase Reveralis 80 g Silica
Cartridge (Grace) as stationary phase, while the mobile phase was composed of n-heptane (solvent A)
and methyl tert-butyl ether (TBME, solvent B). A linear gradient from 0% to 100% B in 40 min and
flow rate of 60 mL/min were applied to elute compound 4 (242 mg) at tR =15 min and 22% of solvent
B. UV detection at 220, 254 and 310 nm, together with electron light scattering detection (ELSD)
were used.
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The supernatant crude extract of H. erinaceus was fractionated by the same Flash chromatography
system, as described above. A reversed phase Reveralis 80 g C18 Flash Cartridge (Grace, Columbia,
MD, USA) was used as a stationary phase and a mixture of deionized water (solvent A) and acetonitrile
(ACN, solvent B) were used as mobile phase. The separation was carried out according to the following
gradient: 35% B isocratic for 5 min, followed by a linear increase to 80% over 50 min, afterwards
increasement to 100% of B in 5 min, and thereafter isocratic conditions at 100% for 5 min. Flow rate of
60 mL/min was applied; UV detection at 220, 254 and 310 nm and ELSD were used. Eight fractions
(S1–S8) were collected and combined to the observed peaks.
Fraction S6 (312 mg), obtained at tR =23 min and 52% of B was further purified on preparative
HPLC using Gilson GX270 Series HPLC system (Gilson Inc., Middleton, WI, USA) and a Nucleodur
C18 column (10 µm; 150 × 40 mm, Macherey Nagel, Düren, Germany) as stationary phase. The mobile
phase consisted of solvent A: H2O + 0.1% triflouroacetic acid and solvent B: ACN + 0.1% triflouroacetic
acid. A gradient was run from 52% B to 75% B in 50 min, with a flow rate 30 mL/min, to give
compound 5 (22 mg) at tR =30 min and 62% of B whereas the fraction (obtained at tR =23 min and
61% B) was repeatedly purified using the same HPLC protocol and a Kromasil C18 column (7 µm;
250 × 21.5 mm, MZ Analysentechnik, Mainz, Germany) as stationary phase to afford the compound 3
(2.24 mg) at tR = 22 min and 69% of B.
Furthermore, fraction S7 (965 mg) obtained at tR = 29 min and 57% of B was subjected to the
reversed phase flash chromatography system that is described above, and the separation was carried
out according to the same protocol that was used for the fractionation of the crude extract of the
supernatant of H. erinaceus. The fraction eluted at tR = 20 min and 67% of B (627 mg) and was further
purified on preparative HPLC using the same conditions as stated above for fraction S6. Compound 1
(6.7 mg) was obtained at tR = 17 min and 58% of B, whereas the fraction eluted at tR = 35 min and 68%
of B was further purified with the same mobile phase composition and the gradient from 54% of B
to 70% in 40 min, flow rate of 15 mL/min and with a Kromasil C18 column (7 µm; 250 × 21.5 mm,
MZ Analysentechnik) as stationary phase to give 6 (1.8 mg) at tR = 31 min and 74% of B.
The supernatant and mycelial extracts of H. flagellum obtained from the fermentation in ZM/2
media were combined and pre-purified using solid phase extraction. A Strata™-X 33 µm Polymeric
Reversed Phase cartridge (Phenomenex, Torrance, CA, USA) was used as a stationary phase,
while methanol (MeOH) was used as a mobile phase. Thereafter, the same preparative HPLC protocol
described for S6 was employed to afford 2 (2.7 mg) at tR = 15 min and 55% of B.
The crude extracts that were obtained from H. flagellum fermented in SP media were pre-purifed
as stated above and fractionated using the same HPLC system with a gradient from 20% B to 80% B in
60 min and flow rate of 14 mL/min. As stationary phase, a Kromasil C18 column (7 µm; 250 × 21.5 mm)
was used. Compounds 7 (1 mg) and 8 (0.3 mg) eluted at tR = 46 min and tR = 38 min, respectively.
3.4. Differentiation Assay
1321N1 astrocyte cells were grown in Gibco™ DMEM (Fischer Scientific, Hampton, NH, USA)
medium containing 10% fetal bovine serum (FCS), and PC12 cells were cultivated in Gibco™ RPMI
1640 (Fischer Scientific, Hampton, NH, USA) medium containing 10% horse serum (HS) and 5%
fetal bovine serum (FCS). In addition, both media were supplemented with penicillin (0.15 mM),
streptomycin (86 µM), and glutamine (2 mM). About 48 h before the compounds were added, 1321N1
cells were seeded on 6-well plates with a density of 1 × 105 cells/well and incubated at 37 ◦C with 5%
CO2. 24 h before adding the compounds, serum free DMEM supplemented with penicillin (0.15 mM),
streptomycin (86 µM), and glutamine (2 mM) was added. After adding the test compounds in different
concentrations the cells were incubated for another 48 h to produce conditioned media. As control,
0.5% ethanol in water was used.
PC12 cells were seeded at a density of 4 × 104 cells/well on a 24-well plate coated with 0.005%
collagen (Roche, Basel, Switzerland) and incubated at 37 ◦C with 5% CO2. After 48 h, either the
compounds or the conditioned media were added. PC12 cells were analyzed by transmitted light
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microscopy for neurite outgrowth. Neurites longer than one cell diameter indicated differentiated
cells. Three independent experiments were performed with approximately 100 cells analyzed each.
3.5. Reverse Transcriptase PCR
For semiquatitative reverse transcriptase assays 1321N1 astrocytes were seeded and incubated
as described above. After incubation with the compounds for six hours, total RNA was isolated
from 1321N1 cells using RNAPure™, peqGOLD (PEQLAB Biotechnologie, Erlangen, Germany).
First-strand cDNA synthesis was performed from 1 µg of the total RNA using AMV reverse
transcriptase (Promega, Madison, WI, USA) and oligo (dT) primer (Promega, Madison, WI,
USA). The following PCR primers were used for amplification which resulted in amplified
PCR-fragments of the following sizes: GAPDH (sense: 5′-TCCACCACCCTGTTGCTGTA-3′; antisense:
5′-CCACAGTCCATGCCATCAC-3′; 451 bp), NGF (sense: 5′-CCAAGGGAGCAGTTTCTATCCTGG-3′;
antisense: 5′-GCAGTTGTCAAGGGAATGCTGAAGTT-3′; 189 bp), BDNF (sense: 5′-TAACGGCGGCA
GACAAAAAGA-3′; anti-sense: 5′-GAAGTATTGCTTCAGTTGGCCT-3′; 101 bp). PCR was performed
in a 25 µL volume containing cDNA template (2 µL), dNTP (10 mM, 0.5 µL), primers (100 µM; 0.1 µL),
Go Taq buffer (5×, 5 µL), and Go Taq polymerase (5 U/µL; 0.2 µL, Promega, Madison, WI, USA).
The amplification programs were started with a step of 94 ◦C for 2 min and finished by a 72 ◦C step for
5 min, while following cycles of amplification were used: GAPDH, 20 cycles: 94 ◦C, 30 s, 60 ◦C, 30 s,
72 ◦C, 45 s; NGF, 30 cycles: 94 ◦C, 30 s, 61 ◦C, 30 s, 72 ◦C, 30 s; BDNF, 30 cycles: 94 ◦C, 30 s, 58 ◦C, 30 s,
72 ◦C, 30 s. GAPDH was used as loading control. The mRNA levels of GAPDH, NGF, and BDNF were
analyzed on a 1% or 2% agarose gel. For comparing the amount of mRNA, FIJI was used [18].
4. Conclusions
In the course of our investigation of secondary metabolites from Hericium spp., two new cyathane
diterpenoid derivatives together with several known metabolites were isolated from the submerged
cultivations of H. erinaceus and H. flagellum. The latter species is very rare and has to the best of our
knowledge never been studied for secondary metabolites. Seven metabolites from both strains were
isolated to purity and were evaluated for their neurotrophin inducing effects. Although none of the
tested compounds showed intrinsic neurothrophic activity, stimulating neurite outgrowth directly
from cultured PC12 cells, compounds 3, 4, 7, and the new derivative 1, clearly enhanced neurotrophin
production in astrocytic cells and can therefore be considered for an upcoming in vivo evaluation.
Moreover, for the first time we observed a promoting effect of cyathane diterpenoid derivatives
on BDNF expression. Since erinacines are able to stimulate the transcription of both investigated
neurothrophins, we suggest an upstream target, which is common to upstream events of both, NGF and
BDNF induction. NGF and BNDF modulatory activities have recently also been reported from an
erinacine containing extract of H. erinaceus [19], and the authors have emphasized the potential of the
fungal extracts for therapy.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/xxx/s1.
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Abbreviations
NGF Nerve growth factor
BDNF Brain derived neurothrophic factor
ESI-MS Electrospray ionization-mass spectrometry
NMR Nuclear Magnetic Resonance
HR-ESI-MS High resolution-Electrospray ionization-mass spectrometry
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
ZM Sugar medium
SP Soy peptone
IR Infrared
DAD Diode array detector
LC Liquid chromatography
EDTA Ethylene-diamine-tetra-acetic acid
DMEM Dulbecco’s modified eagle’s medium
RPMI Roswell park memorial institute medium
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